Clinical Trials Sponsored by AUM Cardiovascular, Inc.

Total 121 results

AUM Cardiovascular, Inc.

Completed

Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study) (AMBIENCE)

Coronary Artery Disease

United States
AUM Cardiovascular, Inc.

Completed

Repeatability and Reproducibility of the CADence™System (SEQUEL)

Coronary Artery Disease

United States
AUM Cardiovascular, Inc.

Withdrawn

Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases (CADENCE)

Coronary Artery Disease

United States
AUM Cardiovascular, Inc.

Completed

Clinical Evaluation of the CADence Device in Detection of Coronary Artery Diseases (TURBULENCE)

Coronary Artery Disease

United States
CorMatrix Cardiovascular, Inc.

Recruiting

CorMatrix Cor TRICUSPID ECM Valve Replacement Study

Tricuspid Valve Disease

United States
Reprieve Cardiovascular, Inc

Completed

Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study

Heart Failure

Georgia
Reprieve Cardiovascular, Inc

Recruiting

Reprieve System Pilot Study

Acute Decompensated Heart Failure

Georgia
TriFlo Cardiovascular, Inc.

Not yet recruiting

Transcatheter Treatment of Tricuspid Valve Regurgitation

Symptomatic Severe Tricuspid Regurgitation

Italy
Reprieve Cardiovascular, Inc

Recruiting

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) (FASTR)

Acute Decompensated Heart Failure

United States
CardioVascular BioTherapeutics, Inc.

Not yet recruiting

Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease

Myocardial Ischemia | Coronary Disease | Coronary Heart Disease | Coronary Arteriosclerosis
CorMatrix Cardiovascular, Inc.

Completed

Restore Myocardial Function With CorMatrix® ECM® Particulate (P-ECM)

Heart Failure

Poland
Reprieve Cardiovascular, Inc

Not yet recruiting

EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU) (FASTR-EU)

Acute Decompensated Heart Failure

Netherlands, Poland
Tioga Cardiovascular, Inc.

Not yet recruiting

Feasibility Study of the Tioga TMVR System

Mitral Regurgitation
CardioVascular BioTherapeutics, Inc.

Unknown

FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease

Peripheral Arterial Disease | Intermittent Claudication | Stenosis

United States
Acorn Cardiovascular, Inc.

Unknown

Confirmation Trial of the Acorn CorCap Cardiac Support Device (CSD) at the Same Time as Mitral Valve Repair (MVR + CorCap)

Heart Failure

United States, Canada
AIM Therapeutics Inc.

Completed

Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma

Asthma

Canada
AIM ImmunoTech Inc.

Terminated

A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects

HIV Infections

United States
AIM ImmunoTech Inc.

Terminated

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

HIV Infection | HIV Seropositivity

United States
AIM ImmunoTech Inc.

Available

Ampligen in Chronic Fatigue Syndrome

Chronic Fatigue Syndrome

United States
AVM Biotechnology Inc

Available

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Cancer | Breast Cancer | Glioblastoma | Gastric Cancer | Pancreatic Cancer | Hodgkin Lymphoma | Ovarian Cancer | Prostate Cancer | Acute Leukemia | Non-hodgkin Lymphoma | Squamous Cell Carcinoma | Tumor, Solid | Tumor, Brain | Spindle Cell Sarcoma
AIM ImmunoTech Inc.

Terminated

Safety Study of FluMist With and Without Ampligen

Influenza, Human

United States
AIM ImmunoTech Inc.

Completed

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

HIV Infection | HIV Seropositivity

United States
AIM ImmunoTech Inc.

Completed

The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome

Chronic Fatigue Syndrome | Myalgic Encephalomyelitis
AIM ImmunoTech Inc.

Completed

Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers

Severe Acute Respiratory Syndrome

Hong Kong
AVM Biotechnology Inc
Medpace, Inc.

Not yet recruiting

Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS (AVM0703)

Covid19 | Influenza, Human | ARDS
AVM Biotechnology Inc
Medpace, Inc.

Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies (OPAL)

Lymphoid Malignancies

United States
Stern Cardiovascular Foundation, Inc.

Terminated

Implementation of a Protocol Utilizing Adaptive CRT in a Normal AV Conduction, CRT Non-Response Population at Generator Replacement

Heart Failure

United States
HUM Nutrition, Inc.
Citruslabs

Completed

Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension

Bloating | Stomach Distended

United States
HUM Nutrition, Inc.
Citruslabs

Completed

An Exploratory Investigation of Dietary Supplementation and Its Effect

Quality of Life

United States
CorMatrix Cardiovascular, Inc.
Yale University

Recruiting

CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study

Tricuspid Valve Insufficiency | Tricuspid Valve Disease

United States
Midwest Cardiovascular Research Foundation
Angiodynamics, Inc.

Active, not recruiting

Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries

Peripheral Arterial Disease

United States
Midwest Cardiovascular Research Foundation
MEDRAD, Inc.

Completed

JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions (JetStreamISR)

Peripheral Vascular Disease | Restenosis

United States
Arkansas Heart Hospital
Cardiovascular Systems Inc

Terminated

Diamondback in Peripheral Vascular Disease (DIAMOND-PAD)

Peripheral Vascular Diseases | Critical Limb Ischemia

United States
CardioVascular BioTherapeutics, Inc.
Warren General Hospital

Completed

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

Diabetes | Venous Stasis Ulcers | Chronic Wounds

United States
University of Calgary
CorMatrix Cardiovascular, Inc.

Completed

Epicardial Infarct Repair Using CorMatrix®-ECM: Clinical Feasibility Study (EIR)

Heart Failure | Acute Coronary Syndrome

Canada
AIM ImmunoTech Inc.
Amarex Clinical Research

Recruiting

Ampligen Compared to No Treatment Following FOLFIRINOX in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Pancreatic Cancer

United States
AIM ImmunoTech Inc.
Amarex Clinical Research

Completed

Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions

Long COVID | Post COVID-19 Condition

United States
Kinderkrankenhaus auf der Bult
Senseonics, Inc.

Completed

Evaluation of the Eversense Continuous Glucose Monitoring System in Type I Diabetic Youth (FNH)

Self Care

Germany
VTBIO Co. LTD
ADM Korea Inc

Completed

Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease (ADD)

Alzheimer's Disease

Korea, Republic of
Laminar, Inc.
Cardiovascular Research Foundation, New York

Enrolling by invitation

Laminar LAAX Pivotal IDE Study

Stroke | Non-valvular Atrial Fibrillation

United States
Inova Health Care Services
CorMatrix Cardiovascular, Inc.

Terminated

CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM (CorMatrix)

Coronary Artery Disease

United States
European Cardiovascular Research Center
RenalGuard Solutions, Inc.

Unknown

Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI (STRENGTH)

Cardiovascular Disease | Acute Kidney Injury

France, Germany
Cardiovascular Imaging Technologies
Astellas Pharma US, Inc.

Unknown

Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress

Coronary Artery Disease

United States
Thoracic & Cardiovascular Healthcare Foundation
Medtronic; AtriCure, Inc.

Unknown

Implanted Loop Recorder Post Atrial Fibrillation Ablation

Atrial Fibrillation

United States
Can-Am HIFU Inc.

Recruiting

Aquablation in Benign Prostatic Hyperplasia in Canada

Urologic Diseases

Canada
Conformal Medical, Inc
Yale Cardiovascular Research Group

Active, not recruiting

The CONFORMAL Early Feasibility Study

Non-valvular Atrial Fibrillation

United States
Roswell Park Cancer Institute
AIM ImmunoTech Inc.

Suspended

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Prostate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer... and other conditions

United States
Can-Am HIFU Inc.

Recruiting

Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).

Urologic Diseases

Canada
Roswell Park Cancer Institute
AIM ImmunoTech Inc.

Terminated

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal

United States
Roswell Park Cancer Institute
AIM ImmunoTech Inc.

Completed

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple -Negative Breast Cancer | Anatomic Stage IV Breast Cancer AJCC

United States

Clinical Trials Sponsored by AUM Cardiovascular, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations